The hypothalamo-pituitary-adrenal (HPA) axis maintains a homeostatic respon
se to stress, infection, or neoplasia. Inflammatory cytokines, including le
ukemia inhibitory factor (LIF), stimulate the HPA axis either directly at t
he pituitary corticotroph, or indirectly through induction of CRH or sympat
hetic noradrenergic neurons, and mediate the immuno-neuroendocrine interfac
e. Unrestrained HPA axis activation leads, however, to immunosuppression. B
ecause suppressor of cytokine signaling-3 (SOCS-3) is a potent inhibitor of
LIF-activated HPA axis, and dynamic interactions between hypothalamus-deri
ved cAMP-inducing neuropeptides and proinflammatory cytokines occur at the
corticotroph level, we investigated SOCS-3 expression in response to peptid
es that stimulate cAMP including CRH, pituitary adenylate cyclase-activatin
g polypeptide, and epinephrine. (BU)(2)cAMP mediates induction of SOCS-3 pr
omoter activity (6.7-fold +/- 0.5, P < 0.001) and SOCS-3 gene expression (4
-fold +/- 0.8, P < 0.005) in a PKA-dependent manner. LIF and cAMP-inducing
agents are additive on SOCS-3 promoter activity (22-fold +/- 2.6, LIF + (BU
)(2)cAMP vs. 7.3-fold +/- 0.6, LIF alone, P < 0.05) and on SOCS-3 transcrip
tion (11.3-fold +/- 2.1, LIF + (Bu)(2)cAMP vs. 9.3-fold +/- 1, LIF alone, P
< 0.05), suggesting alternate pathways for LIF and cAMP-mediated corticotr
oph signaling. Similarly, LIF and CRH or pituitary adenylate cyclase-activa
ting polypeptide are additive for SOCS-3 promoter activity and transcriptio
n (P < 0.05). Whereas signal transducer and activator of transcription 3 bi
nding to the SOCS-3 promoter mediates LIF action, several SOCS-3 promoter r
egions containing cAMP-responsive elements are required for cAMP-PKA effect
. Thus, both classes of POMC-inducing agents, cytokines as well as cAMP-ind
ucing central peptides, regulate SOCS-3, providing a further level of negat
ive HPA axis control during inflammation. These results indicate a sensitiv
e intracellular autoregulation of corticotroph function.